About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD9.46
- USD9.65
- USD9.31
- USD14.44
- -1.50%
- --
- 36.00
- 1.09M
- 801M
- 3.41
- 177.90%
Stock News
21 minutes ago
Massive power outage strikes Spain and Portugal
MarketWatch
1 hour ago
Agriculture isn't nearing trade war tariffs crisis, 'it is full blown crisis already' farmers say
CNBC
4 hours ago
Risk-Off Following Familiar Pattern
SeekingAlpha
4 hours ago
Baron Emerging Markets Fund Q1 2025 Shareholder Letter
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
